Ratnatris Pharmaceuticals Private Limited

Senores Pharmaceuticals disclosed subsidiary capacity expansions totaling ₹43 crores via a SEBI Reg. 30 filing. Havix Group USA plans to increase capacity from 1.2Bn to 2.0Bn units at a cost of ₹18 cr